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Introduction
Signaling by ligands of receptor tyrosine kinases (RTKs) is criti-
cal for the stimulation and regulation of neuronal differentiation. 
Neurotrophins, for instance, act through specifi  c members of 
the Trk RTK family to activate multiple signaling pathways that 
alter protein activities and gene expression and thereby promote 
neuronal differentiation and function (for review see Reichardt, 
2006). Targeted deletion of the neurotrophin nerve growth 
factor (NGF), or of its receptor TrkA, results in decreased inner-
vation of the spinal cord, hippocampus, and cerebral cortex as 
well as of target organs such as the skin. In addition, NGF/TrkA 
signaling is essential for the survival of particular subgroups of 
neurons in trigeminal, sympathetic, and dorsal root ganglia (DRG) 
(Crowley et al., 1994; Smeyne et al., 1994).
Binding of neurotrophins to Trk receptors results in re-
ceptor dimerization, autophosphorylation, and in the subsequent 
activation of multiple signaling pathways such as the ERK/MAP 
kinase, phosphatidylinositol 3-kinase (PI-3K), and phospho-
lipase C-γ (PLC-γ) pathways. Activation of the ERK1/2 MAP 
kinase pathway is directed through the recruitment of adaptor 
proteins such as Shc, Grb2, FRS2, SH2-B, and Gab1 to the re-
ceptor complex, through multiple redundant mechanisms (for 
review see Reichardt, 2006). In addition, the SH2 domain con-
taining tyrosine phosphatase, SHP2, is necessary for the sus-
tained, but not for the transient, activation of the ERK1/2 MAP 
kinase pathway and for the stimulation of neuronal differentia-
tion downstream of NGF and other growth factors (Goldsmith 
and Koizumi, 1997; Wright et al., 1997; Hadari et al., 1998; for 
review see Neel et al., 2003; Rosário and Birchmeier, 2003). 
SHP2 becomes activated through a conformational change in-
duced by binding of the SHP2 SH2 domains to phosphorylated 
tyrosine residues on multiadaptor proteins (Lechleider et al., 
1993; Pluskey et al., 1995; Ong et al., 1997; Hof et al., 1998).
Another ERK MAP kinase, ERK5 (also known as Big 
MAP kinase), is also activated downstream of neurotrophins, 
although the exact mechanism involved is not known (Cavanaugh 
et al., 2001; Watson et al., 2001). ERK1/2 and ERK5 have 
similar kinase domains and have been shown to share many 
downstream substrates, but there are also important differences 
(for review see Wang and Tournier, 2006). Although both 
  kinases are required for neuronal differentiation in Xenopus, 
ERK1/2 appears to regulate neuronal induction while ERK5 
regulates subsequent neuronal differentiation (Pera et al., 2003; 
Kuroda et al., 2005; Nishimoto et al., 2005). Moreover, ERK5 
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but not ERK1/2 promotes transcription and cellular survival 
  after NGF-stimulation of distal axons in mature neurons (Watson 
et al., 2001).
The Rho family GTPases Rac and Cdc42 become acti-
vated downstream of a variety of stimuli, including NGF, and 
regulate various aspects of neuronal differentiation, from neu-
rite formation and axon outgrowth to growth cone function and 
dendritic maturation (Lamoureux et al., 1997; Yasui et al., 2001; 
Aoki et al., 2004). Cycling of these GTPases between GTP- and 
GDP-bound states is essential for their function and is regulated 
by binding to guanine nucleotide exchange factors (GEFs), 
  GTPase activating proteins (GAPs), and guanine nucleotide dis-
sociation inhibitors (GDIs). Loss-of-function mutations in certain 
of these regulators are associated with human diseases that 
affect the nervous system, including mental retardation and the 
degenerative motor neuron disease, amyotrophic lateral sclerosis 
(for review see Govek et al., 2005).
We have here identifi  ed a novel regulator of neuronal 
process extension, the neurite outgrowth multiadaptor GTPase-
  activating protein, NOMA-GAP, which belongs to a new family 
of multiadaptor proteins with RhoGAP activity. We show that 
NOMA-GAP is required for NGF-stimulated neurite outgrowth 
and extension and for the regulation of the ERK5 and Cdc42 
pathways downstream of NGF. NOMA-GAP is directly associ-
ated with the NGF receptor, TrkA, and functions both as a GAP 
for Cdc42 and, upon tyrosine phosphorylation, as a multiadaptor 
protein, to recruit SHP2, Shc, and Grb2 proteins. We show that 
recruitment of SHP2 by NOMA-GAP is required for the exten-
sion of neuronal processes and for the activation of the ERK5 
MAP kinase. Furthermore, we demonstrate that NOMA-GAP 
negatively regulates the activation of Cdc42 and PAK after 
stimulation by NGF and that this activity is also critical for the 
formation of neuronal processes.
Results
Novel family of neuronal RhoGAP 
domain–containing adaptor proteins
We have searched for novel regulators of Rho family GTPases, 
which are involved in the control of neuronal differentiation, 
by expression profi  ling of E12-E14 mouse spinal cords and 
DRG (unpublished data). We identifi  ed a gene highly expressed 
in differentiating neurons that codes for a protein containing a 
RhoGAP domain, an incomplete Phox (PX) domain, and an SH3 
domain. We have named this gene neurite outgrowth multiadaptor 
RhoGAP protein, NOMA-GAP (Fig. 1 A). NOMA-GAP has pre-
viously been entered in the human genome database (GenBank) 
under the name sorting nexin 26 (Gene ID 115703) due to the 
presence of the PX-like domain, which represents the only struc-
tural consensus between true sorting nexins and NOMA-GAP. 
Figure 1.  Structure and expression pattern of NOMA-GAP and RICS. (A) Schematic representation of the structure of human NOMA-GAP and RICS 
  proteins. Phox (PX), Phox-like (´PX´), SH3, and RhoGAP domains are indicated. Additional homology regions are shaded light blue. The degree of amino acid 
identity of particular domains between the proteins is given in percentages. Novel RICS N-terminal sequences are indicated by a thick blue line. (B) Ex-
pression of NOMA-GAP mRNA (blue-purple) is shown in whole mount and in mid-thoracic transverse sections of murine embryos (E8.5 to E11.5). Multiple 
probes to distinct portions of the NOMA-GAP and RICS gene were tested, with similar results. Sections from E11.5 embryos have been counterstained with 
Nuclear Fast Red (pink). Immunostaining for neuroﬁ  lament (NF) of an adjacent section is shown in red. (C) Localization of endogenous NOMA-GAP protein 
(green) in transverse sections of mouse embryos (E11). NF staining is shown in red. (D) Localization of endogenous NOMA-GAP in NGF-stimulated PC12 
cells. NOMA-GAP staining is shown in green. The two bottom panels show magniﬁ  cations of the growth cones of PC12 cells stimulated with NGF for 5 d 
and co-stained for endogenous NOMA-GAP (green) and either total membrane or polymerized actin as indicated (red). Filled arrows indicate selected 
points of NOMA-GAP accumulation; empty arrows indicate microspikes emanating from neurite tips.NEURONAL DIFFERENTIATION BY NOMA-GAP • ROSÁRIO ET AL. 505
An alternatively spliced form of the murine NOMA-GAP homo-
logue, which is not present in humans, has been described as 
a regulator of insulin-stimulated glucose uptake in adipocytes 
(Chiang et al., 2003). As we have identifi  ed an alternative func-
tion, we will use the name NOMA-GAP (Fig. 1 A).
Sequence comparison of NOMA-GAP with human Gen-
Bank sequences revealed another gene sharing 47% overall 
sequence identity as well as structural similarity with huNOMA-
GAP (Fig. 1 A). Partial sequences of the rat and mouse homo-
logues, which lack the N-terminal region containing the PX and 
SH3 domains, had been previously named RICS, GC-GAP, or 
GRIT (Nakamura et al., 2002; Okabe et al., 2003; Zhao et al., 
2003). Given the high degree of structural and sequence identity 
between these two genes, we propose that they form a novel 
family of signaling molecules (Fig. 1 A; Fig. S1, available at 
http://www.jcb.org/cgi/content/full/jcb.200609146/DC1).
NOMA-GAP is fi  rst expressed in the neural tube of mouse 
embryos as early as E8.5, and during development of the central 
nervous system, expression increases along the anterior-posterior 
axis (Fig. 1 B, top left panels). Analysis of transverse sections 
shows that NOMA-GAP expression precedes terminal neuronal 
differentiation, as determined by staining for the post-mitotic 
neuronal marker neurofi  lament (NF; Fig. 1 B, bottom panels). 
Strong expression is also seen in the peripheral nervous system in 
the DRGs (Fig. 1 B). NOMA-GAP is also expressed in other 
neuronal tissues such as in the brain and in the eye (Fig. S2, avail-
able at http://www.jcb.org/cgi/content/full/jcb.200609146/DC1; 
and unpublished data). RICS is not expressed in the spinal cord 
during stages of neuronal differentiation, E8.5 to E14 (Fig. 1 B). 
We have also analyzed the location of NOMA-GAP protein in 
transverse sections of mouse embryos, using specifi  c antibodies 
raised against the C terminus of NOMA-GAP (Fig. 1 C; see   
Materials and methods). NOMA-GAP protein is found in dis-
tinct punctate staining along, and at the ends, of axons project-
ing from the spinal cord (Fig. 1 C). To localize NOMA-GAP 
at the cellular level, we have used PC12 neuronal precursor 
cells, which differentiate upon the addition of NGF (Greene 
and Tischler, 1976). NOMA-GAP is evenly distributed in a fi  ne 
punctate pattern around the cell periphery in unstimulated cells. 
Stimulation with NGF results in the extension of neuronal pro-
cesses and the preferential accumulation of NOMA-GAP punc-
tate staining at these early protrusions. NOMA-GAP is also 
present at the growth cones of differentiated cells (Fig. 1 D, 
indicated by arrows). We have controlled for the higher level of 
membrane at the growth cones by co-staining samples with a 
lipophilic styryl dye (in red; Fig. 1 D, third panel). In addition, 
co-staining of polymerized actin, shows that NOMA-GAP is 
Figure 2.  NOMA-GAP is required for NGF-stimulated process extension. 
(A) Down-regulation of endogenous NOMA-GAP protein in NGF-stimulated 
PC12 cells transfected with control siRNA (controlsi) or siRNA directed against 
rat NOMA-GAP (NOMAsi). NOMA-GAP immunoprecipitates (IP) were 
  immunoblotted (IB) for NOMA-GAP. Lysates were also immunoblotted for 
ERK1/2. (B) Down-regulation of immunoﬂ  uorescent staining for endogenous 
NOMA-GAP in NGF-stimulated siRNA-transfected PC12 cells. Cells were 
transfected with control siRNA or NOMA-GAP siRNA in the presence of 
  limiting amounts of the transfection marker, GFP, and immunostained for 
endogenous NOMA-GAP. Mean pixel intensity of NOMA-GAP staining 
per GFP-positive cell is shown. The mean staining of controlsi (n = 40) and 
NOMAsi (n = 56) samples were compared with a t test for unequal vari-
ances and found to be signiﬁ  cantly different (P < 0.0005; see Materials and 
methods). (C) Effect of down-regulation of NOMA-GAP expression on NGF-
stimulated differentiation in PC12 cells. Cells transfected with control siRNA, 
NOMA-GAP siRNA, or RICS siRNA were stained for polymerized actin (red) 
and the transfection marker GFP (green) 72 h after transfection. Arrows indicate 
selected transfected cells. Bar, 20 μm. (D) Quantiﬁ  cation of neuronal pro-
cess extension in siRNA-transfected PC12 cells (ﬁ  ve independent experiments). 
Total processes, cells bearing processes >30 μm long; long processes, 
cells bearing processes >100 μm long. The means of the four samples were 
compared with the multiple test of ANOVA and found to be signiﬁ  cantly 
different (P < 0.0005). The error probabilities of pairwise tests were cor-
rected by Bonferroni. The means of the control and NGF+NOMAsi samples 
were found to be signiﬁ  cantly different from the mean of the NGF+controlsi 
sample (P < 0.0005 in both cases for Total processes and P < 0.0005 
and P < 0.001, respectively for Long processes; summarized by asterisks; 
see Materials and methods). Percentages denote level of inhibition.JCB • VOLUME 178 • NUMBER 3 • 2007  506
concentrated in the body of the growth cone but absent in the 
microspikes emanating from the neurite tips (in red; Fig. 1 D, 
indicated by arrows in last panel).
NOMA-GAP is required for NGF-induced 
neurite extension
We have analyzed the role of NOMA-GAP during NGF-
  stimulated neuronal differentiation using siRNA directed against 
rat NOMA-GAP in PC12 cells, which express both NOMA-GAP 
and RICS (Fig. S1 C). Transfection of siRNA to NOMA-GAP 
signifi  cantly reduced NOMA-GAP expression as visualized 
both in immunoprecipitates (Fig. 2 A) and in fi  xed cells immuno-
stained for endogenous NOMA-GAP (Fig. 2 B). NGF stim-
ulates the transient cell fl  attening of PC12 cells followed by 
neurite outgrowth and extension over several days (Greene 
and Tischler, 1976). We determined the proportion of trans-
fected cells forming neurites (>30 μm long; total processes) 
or containing long axonal-like processes (>100 μm long; long 
processes). Remarkably, down-regulation of NOMA-GAP ex-
pression by siRNA inhibited the extension of neuronal pro-
cesses and resulted in cell fl  attening and spreading (Fig. 2 C, 
indicated by arrows). The formation of long neuronal processes 
was inhibited by over 50% in response to down-regulation of 
NOMA-GAP (Fig. 2 D). Down-regulation of RICS, on the other 
hand, did not inhibit neurite outgrowth and elongation (Fig. 2 D; 
Nasu-Nishimura et al., 2006). These data suggest that NOMA-
GAP is required for NGF-stimulated neurite outgrowth.
We then examined whether NOMA-GAP is part of the sig-
naling complex that becomes recruited to the NGF receptor, 
TrkA. Immunoprecipitation of endogenous TrkA from PC12 
cells resulted in the coimmunoprecipitation of endogenous 
NOMA-GAP and Shc proteins (Fig. 3 A). Unlike Shc, NOMA-
GAP formed a constitutive, NGF-independent complex with 
the receptor. NGF-stimulation resulted in the strong tyrosine 
phosphorylation of the associated NOMA-GAP (Fig. 3 A). We 
confi  rmed that NOMA-GAP interacts directly with TrkA by ex-
pressing N- and C-terminal deletion mutants of huNOMA-GAP 
with the cytoplasmic domain of huTrkA in the yeast two-hybrid 
system (Fig. 3 B). Expression of a deletion mutant of NOMA-
GAP containing the SH3 and RhoGAP domains (SH3-GAP) 
  interacted with the TrkA cytoplasmic domain and enabled growth 
of the transfected yeast on selection plates (Fig. 3 C). No inter-
action was seen with the N-terminal 186 amino acids containing 
the PX domain (´PX´), the C-terminal region of NOMA-GAP 
(Cterm), or with the isolated SH3 domain of NOMA-GAP (Fig. 3, 
B and C). Together, these data show that NOMA-GAP inter-
acts directly with the cytoplasmic domain of TrkA, through an 
N-terminal region that includes residues 279–782.
We then dissected the function of the different domains of 
NOMA-GAP in PC12 cells (Fig. 4; Fig. S3, available at http://
www.jcb.org/cgi/content/full/jcb.200609146/DC1). Transfected 
cells were stimulated for a short period (48 h) with NGF, during 
which time control cells start to differentiate, but have not yet 
formed long neuronal processes (Fig. 4 B, top left column). 
Samples were then scored for the proportion of transfected cells 
bearing short neurites (30–100 μm), long processes (>100 μm), 
or no neurites. Expression of NOMA-GAP alone did not affect 
cellular morphology during this time period. However, NOMA-
GAP strongly synergized with NGF in the formation and ex-
tension of neuronal processes (Fig. 4 B, top middle column; 
Figure 3.  NOMA-GAP interacts with TrkA. (A) Coimmunoprecipitation of endogenous NOMA-GAP and TrkA from NGF-stimulated PC12 cells. TrkA immuno-
precipitates were immunoblotted (IB) as indicated. (B) Diagrammatic representation of the GAL4 activation domain: NOMA-GAP fusion constructs used for 
yeast two-hybrid analysis. (C) Interaction of huNOMA-GAP with the cytoplasmic domain of huTrkA in the yeast two-hybrid system. The growth of trans-
formed yeast on plates selecting for protein interaction (Selection plate) or for the presence of both plasmids (Total growth plate) is shown.NEURONAL DIFFERENTIATION BY NOMA-GAP • ROSÁRIO ET AL. 507
quantifi  ed in Fig. 4 C). NOMA-GAP mutants, where the RhoGAP 
domain (delRhoGAP), the whole N-terminal region (containing 
the PX, SH3, and RhoGAP domains; Cterm), or the C-terminal 
region (Nterm) had been deleted, failed to induce the extension 
of long neuronal processes. The formation of shorter neurites 
was not affected (Fig. 4 B; quantifi  ed in Fig. 4 D). This suggests 
that both the RhoGAP domain, and sequences in the C-terminal 
region of NOMA-GAP are required for the stimulation of neu-
rite extension. The PX domain, on the other hand, negatively 
regulates NOMA-GAP function, as deletion of this domain 
(delPX) stimulates NOMA-GAP–induced process outgrowth 
(Fig. 4 B, bottom right column; quantifi  ed in Fig. 4 D). PX 
domains have been reported to negatively regulate protein 
activity in other proteins with tandem PX-SH3 domains (Yuzawa 
et al., 2004).
NOMA-GAP recruits the tyrosine 
phosphatase SHP2
Next we examined the signaling function of the C-terminal 
region of NOMA-GAP (residues 965–1287), which is rich in 
Figure 4.  NOMA-GAP stimulates the extension of long neuronal processes. (A) Schematic representation of wild-type (wt) and deletion mutant NOMA-
GAP constructs. (B) NOMA-GAP stimulates the extension of long neuronal processes in PC12 cells stimulated with low levels of NGF for 48 h. Samples 
were stained as described in Fig. 2 C. (C) Summary of the average percentage of GFP-positive cells bearing short or long neuronal processes in three inde-
pendent experiments. (D) Quantiﬁ  cation of the effect of different NOMA-GAP deletion mutants on the extension of long neuronal processes in three inde-
pendent experiments. The means of the different samples were compared as described in Fig. 2 D. The means of the wt and delPX samples were found to 
be signiﬁ  cantly different from the mean of the control sample (P < 0.01 and P < 0.0005, respectively).JCB • VOLUME 178 • NUMBER 3 • 2007  508
  tyrosine residues that lie within consensus sites for the binding 
of SH2 domains. We performed a modifi  ed yeast two-hybrid screen 
using this portion of NOMA-GAP and a human brain cDNA 
  library (HY4004AH). An activated mutant of the tyrosine kinase 
Src (Y416F Y527F) was coexpressed from the same vector 
to enable tyrosine phosphorylation of NOMA-GAP (see also 
  Materials and methods). We identifi  ed several clones encoding the 
N-terminal region of the tyrosine phosphatase SHP2 as well as 
full-length clones of the adaptor proteins Grb2 and Shc (Fig. 5, 
B and C). The C terminus of NOMA-GAP contains a consensus 
binding site for the Grb2 SH3 domain (PXXPXR; Simon and 
Schreiber, 1995), which may explain weak binding of Grb2 to 
NOMA-GAP in the absence of tyrosine phosphorylation (Fig. 5 C). 
Both full-length and the N terminus of SHP2 interacted with the 
C terminus of NOMA-GAP in a Src-dependent fashion (Fig. 5, 
B and D). The N terminus of SHP2 contains two SH2 domains, 
and binding to NOMA-GAP is abrogated by mutation of the 
conserved arginine residues in the phosphotyrosine binding pock-
ets of these domains (RK mutant, Fig. 5 B; O’Reilly and Neel, 
1998). This indicates that interaction with SHP2 is mediated 
through phosphorylated tyrosine residues on NOMA-GAP. To 
identify the SHP2-binding site on NOMA-GAP, we mutated all 
tyrosine residues in the C-terminal region of NOMA-GAP found 
in the consensus YXXI/V/L sequence for SHP2 binding (for 
  review see Neel et al., 2003; Rosário and Birchmeier, 2003). 
Mutation of a single tyrosine in the C terminus of NOMA-GAP, 
residue 1169, abolished the direct interaction of NOMA-GAP with 
SHP2 but had no effect on the binding of Grb2 or Shc (Fig. 5, 
A and D). Mutation of other tyrosine residues, for example tyro-
sine 1119, had no effect on SHP2 binding to NOMA-GAP.
SHP2 is activated through a conformational change in-
duced by binding of tyrosine-phosphorylated proteins to its 
SH2 domains (Hof et al., 1998). Because NOMA-GAP binds to 
SHP2 through the SHP2 SH2 domains, it should lead to the 
  activation of this phosphatase. We confi  rmed this by incubating 
recombinant wild-type GST-tagged SHP2 with lysates from 
  serum-stimulated cells expressing full-length or the C terminus 
of NOMA-GAP. Recombinant SHP2 was recovered by incuba-
tion with glutathione-Sepharose beads, and phosphatase activity 
assayed on the artifi  cial substrate pNPP. Indeed, expression of 
both full-length and the C terminus of NOMA-GAP stimulated 
SHP2 phosphatase activity (Fig. 5 E).
To test whether the SHP2 binding site on NOMA-GAP, 
residue 1169, is a major phosphorylation site downstream of 
Figure 5.  The C terminus of NOMA-GAP acts as a docking site for multiple signaling effectors. (A) Schematic representation of the NOMA-GAP and SHP2 
constructs used for yeast two-hybrid analysis (where C-term refers to C terminus of NOMA-GAP; ﬂ   to full-length SHP2; Nterm to the N terminus of SHP2). 
(B–D) Yeast growth under selection for the reconstitution of GAL4 transcriptional activity. (B) Interaction of NOMA-GAP Cterm with wild-type and RK mutant 
SHP2 Nterm. (C) Interaction of NOMA-GAP Cterm with Shc and Grb2. (D) Interaction of point mutants of NOMA-GAP Cterm with SHP2, Shc, and Grb2. 
(E) NOMA-GAP activates SHP2 phosphatase activity. Recombinant wt GST-SHP2 incubated with lysates derived from serum-stimulated NIH3T3 cells ex-
pressing full-length NOMA-GAP or NOMA-GAP Cterm, was recovered by precipitation with glutathione-Sepharose beads and phosphatase activity mea-
sured on pNPP. The average of two independent experiments is shown. (F) Tyrosine phosphorylation of wild-type and Y1169A NOMA-GAP after NGF 
stimulation. Myc-tagged wt and Y1169A NOMA-GAP were immunoprecipitated from NGF-stimulated and unstimulated transiently transfected PC12 cells. 
Precipitates and lysate were immunoblotted as indicated. (G) Coimmunoprecipitation of endogenous SHP2 and Grb2 with endogenous NOMA-GAP from 
unstimulated and NGF-stimulated PC12 cells. NOMA-GAP and beads-alone control (C) precipitates and lysate were immunoblotted as indicated. Asterisk 
marks a nonspeciﬁ  c band. (H) Coimmunoprecipitation of endogenous NOMA-GAP with endogenous SHP2 from unstimulated and NGF-stimulated PC12 
cells. SHP2 and beads-alone control (C) precipitates were immunoblotted as indicated.NEURONAL DIFFERENTIATION BY NOMA-GAP • ROSÁRIO ET AL. 509
NGF, we analyzed tyrosine phosphorylation of Myc-tagged 
wild-type and Y1169A NOMA-GAP immunoprecipitated from 
NGF-stimulated PC12 cells. Wild-type NOMA-GAP is weakly 
phosphorylated on tyrosine residues in cells grown in reduced 
serum and becomes strongly phosphorylated upon stimulation 
with NGF (Fig. 5 F). Mutation of residue 1169 signifi  cantly re-
duced tyrosine phosphorylation of NOMA-GAP, indicating that 
this is a major tyrosine phosphorylation site downstream of 
NGF. Expression of dominant-negative SHP2, which contains 
a 31-amino acid deletion in the phosphatase domain (DNSHP2; 
O’Reilly and Neel, 1998), did not signifi  cantly alter tyrosine 
phosphorylation on NOMA-GAP (Fig. 5 F), suggesting that 
NOMA-GAP is not a major substrate for SHP2.
We confi  rmed that NOMA-GAP associates with SHP2 
downstream of NGF signaling in two-way immunoprecipita-
tions of endogenous proteins from NGF-stimulated PC12 cells. 
Immunoprecipitation of NOMA-GAP resulted in the coimmuno-
precipitation of SHP2 only upon stimulation with NGF (Fig. 5 G). 
NOMA-GAP also associated with Grb2, and this was enhanced 
by stimulation with NGF. Immunoprecipitation of endogenous 
SHP2 confi  rmed that NGF stimulates the association of NOMA-
GAP with SHP2 in PC12 cells (Fig. 5 H).
SHP2 is required for NOMA-GAP–induced 
signaling and neurite extension
We interfered with SHP2 function downstream of NOMA-GAP 
by either mutating the SHP2 binding site on full-length NOMA-
GAP (Y1169A, Fig. 6 A) or by coexpressing DNSHP2. Inter-
fering with SHP2 function inhibited NOMA-GAP-induced 
extension of neuronal processes in NGF-stimulated PC12 cells 
(Fig. 6 B; quantifi  ed in Fig. 6 C). We then analyzed whether 
wild-type and mutant human NOMA-GAP could rescue the in-
hibition of NGF-induced neurite outgrowth caused by down-
regulation of endogenous NOMA-GAP (Fig. 6 D). Expression 
of wild-type human NOMA-GAP, but not of Y1169A or N- and 
C-terminal deletion mutants, rescued NGF-stimulated neurite 
outgrowth in PC12 cells treated with NOMA-GAP siRNA 
(Fig. 6 D; quantifi  ed in Fig. 6 E).
Figure 6.  SHP2 is required for NOMA-GAP–
stimulated neurite extension. (A) Schematic 
representation of full-length wild-type, mutant, 
and deletion NOMA-GAP constructs. (B and C) 
SHP2 is required for NOMA-GAP–stimulated 
process extension. PC12 cells were transfected 
with wild-type and mutant NOMA-GAP and, 
where indicated, dominant-negative SHP2 
(DNSHP), in the presence or absence of low 
levels of NGF. Samples were stained for po-
lymerized actin (red) and for GFP cotransfected 
at limiting amounts (green) 48 h after trans-
fection. Bar, 20 μm. (C) Quantiﬁ  cation of four 
  independent experiments. The means of the 
different samples were compared as described 
in Fig. 2 D. Only the mean of the wt sample 
was found to be signiﬁ  cantly different from the 
control mean (P < 0.008). (D and E) Expression 
of full-length human NOMA-GAP, but not the 
full-length Y1169A point mutant nor C- and 
N-terminal deletion mutants, rescues NGF-
stimulated process formation in NOMA-GAP 
siRNA (NOMAsi)-treated PC12 cells. Samples 
were stained as before. Bars, 20 μm. (E) Quan-
tiﬁ  cation of the proportion of GFP-positive cells 
bearing long neuronal processes (three inde-
pendent experiments). The means of the different 
samples were compared as described in Fig. 2 D. 
Only the means of the controlsi (P < 0.037) 
and NOMAsi+wt NOMA-GAP (P < 0.0005) 
samples were found to be signiﬁ  cantly different 
from NOMAsi.JCB • VOLUME 178 • NUMBER 3 • 2007  510
We also analyzed the function of NOMA-GAP in the 
spinal cord by using in ovo electroporation of chick embryos. 
Using this technique, cells in the proliferative ependymal layer 
on one side (Fig. 7 A; right-hand side, top row) of the spinal 
cord are electroporated at stages preceding endogenous neuronal 
differentiation. These cells then populate that entire half of the spi-
nal cord. Expression of wild-type or delPX human NOMA-GAP 
resulted in the premature differentiation of cells in the prolifera-
tive ependymal layer (as shown by staining for the post-mitotic 
neuronal marker NeuN; quantifi  ed in Fig. 7 B) and the pro-
jection of neuronal processes from these cells (neurofi  lament 
staining; indicated by arrows, second column, Fig. 7 A). This was 
abrogated by mutation of the SHP2 binding site in NOMA-GAP 
(Y1169A, last column, Fig. 7 A; quantifi  ed in Fig. 7 B). Together, 
the above data indicate that recruitment of SHP2 through the 
C-terminal domain is required for the function of NOMA-GAP 
in neuronal process extension and differentiation.
NOMA-GAP regulates the activation of the 
ERK5 MAP kinase downstream of NGF
SHP2 has been shown to regulate the activation of the Ras/
ERK1/2 MAP kinase pathway (for review see Neel et al., 2003; 
Rosário and Birchmeier, 2003). Indeed, NOMA-GAP–stimulated 
neurite extension in PC12 cells was inhibited by the MAP ki-
nase pathway inhibitor U0126 or by a dominant-negative mutant 
of Ras (N17Ras; Fig. 8 A, quantifi  ed in Fig. 8 B). Moreover, 
overexpression of wild-type NOMA-GAP resulted in the strong 
activation of the Elk1 reporter in epithelial cells (Fig. 8 C). Activ-
ity was dependent on interaction with SHP2, as mutation of the 
SHP2 binding site Y1169 strongly inhibited transcriptional acti-
vation of Elk1. We also analyzed whether NOMA-GAP could 
stimulate MAP kinase activation in PC12 cells. PC12 cells ex-
pressing wild-type or Y1169A NOMA-GAP were stimulated 
with NGF either for 24 h (Fig. 8 D) or for shorter time periods 
(Fig. 8 E). To our surprise, NOMA-GAP did not signifi  cantly al-
ter the phosphorylation (and thus activation) of the classical MAP 
kinases, ERK1 and 2, but resulted in the sustained elevated acti-
vation of ERK5. Cells expressing Y1169A NOMA-GAP, on the 
other hand, showed an elevation in the transient activation of 
ERK5 but then a rapid loss in ERK5 phosphorylation (Fig. 8 E, 
quantifi  ed in Fig. 8 F). A similar result was observed upon coex-
pression of DNSHP2 with NOMA-GAP (unpublished data). 
Down-regulation of endogenous NOMA-GAP in PC12 cells, on 
the other hand, resulted in a decrease in the sustained (1 h),  but 
not in transient (5 min), activation of ERK5 and had no effect on 
the activation of ERK1/2 (Fig. 8 G). Furthermore, ERK5 activa-
tion in NOMA-GAP down-regulated PC12 cells could be rescued 
by coexpression of wild-type but not of Y1169A NOMA-GAP 
(Fig. 8 G). NOMA-GAP thus regulates sustained activation of 
ERK5 downstream of NGF, through recruitment of SHP2.
Figure 7.  NOMA-GAP stimulates neuronal differentiation in the developing chick spinal cord. (A) Mid-thoracic transverse sections of the spinal cords 
of chick embryos electroporated 48 h earlier, at HH stages 15–17, with GFP or Myc-tagged wild-type and mutant NOMA-GAP constructs. The electro-
porated side is shown on the right-hand side of the spinal cord. Adjacent sections were stained for expression of the tagged-electroporated protein 
(green) and the neuronal markers NeuN and NF (red). Arrows indicate up-regulation of NeuN staining in the proliferative ependymal layer and the ex-
tension of neuronal processes in NOMA-GAP–expressing cells. (B) Quantiﬁ  cation of NeuN expression. Cell nuclei were counterstained with TOTO-3 
for identiﬁ  cation of individual cells for counting (see Materials and methods). The percentage of GFP- or NOMA-GAP–expressing cells expressing NeuN 
is shown as black bars, while the proportion of NeuN expressing cells in the nonelectroporated side of the same embryos is shown as white bars. Five 
embryos were each analyzed for wt and Y1169A NOMA-GAP and two embryos for GFP electroporations. The means of the different samples were 
compared as described in Fig. 2 D. Only the mean of the wt electroporated cells was found to be signiﬁ  cantly different from the respective GFP mean 
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NOMA-GAP negatively regulates 
the Cdc42/PAK signaling pathway 
downstream of NGF
Binding assays of the RhoGAP domain of NOMA-GAP with 
dominant-active and -negative forms of Cdc42 and other 
RhoGTPases showed that NOMA-GAP preferentially binds to 
active Cdc42 (Fig. S5, available at http://www.jcb.org/cgi/
content/full/jcb.200609146/DC1). We studied whether NOMA-
GAP regulated the Cdc42 signaling pathway downstream of 
NGF in PC12 cells. We used antibodies to the autophosphoryla-
tion sites on the S/T kinase PAK 1/2, which lies downstream of 
Cdc42 in NGF-stimulated PC12 cells (Obermeier et al., 1998). 
Down-regulation of NOMA- GAP resulted in the inhibition of 
ERK5 as observed before, but also in a strong elevation in the 
autophosphorylation, and thus activation, of PAK (Fig. 9 A). 
Furthermore, we could rescue this elevation by coexpression of 
hNOMA-GAP (Fig. 9 B). A partial rescue was seen upon co-
expression of the SHP2 binding mutant, Y1169A NOMA-GAP 
(Fig. 9 B), suggesting that SHP2 may play a small role in the 
regulation of PAK downstream of NOMA-GAP. We also analyzed 
the levels of GTP-Cdc42 in NOMA-GAP siRNA-treated PC12 
cells, using a pull-down assay with the Cdc42/Rac-interactive 
binding (CRIB) domain of PAK (Fig. 9 C). Down-regulation of 
NOMA-GAP resulted in increased Cdc42-GTP in NGF-stimulated 
and unstimulated PC12 cells. Thus, NOMA-GAP is an impor-
tant negative regulator of Cdc42/PAK signaling downstream 
of NGF.
Expression of dominant-active Cdc42 (V12 Cdc42) in 
PC12 cells is inhibitory to neurite outgrowth, and induces in-
stead cell fl  attening and spreading as well as fi  lopodia forma-
tion (Nobes and Hall, 1995; Daniels et al., 1998; Aoki et al., 
2004). This could be reversed by coexpression of NOMA-GAP 
(Fig. 9, D and E). PC12 cells treated with NOMA-GAP siRNA 
exhibit a similar, although less extensive, phenotype (Fig. 2 D 
and Fig. 9 H). We asked whether the inhibition of neurite out-
growth caused by down-regulation of NOMA-GAP is due to the 
elevated activation of Cdc42 observed in these cells. We there-
fore titrated dominant-negative Cdc42 (N17Cdc42) into NGF-
stimulated NOMA-GAP or control siRNA-treated PC12 cells 
(Fig. 9 F). As has been previously observed (Daniels et al., 
1998), expression of N17Cdc42 in controlsi-treated NGF-
stimulated cells resulted in inhibition of neurite outgrowth and 
the cells showed a round undifferentiated phenotype (Fig. 9 H, 
first column; quantified in Fig. 9 G). Down-regulation of 
NOMA-GAP leads to cell fl  attening. Expression of low levels of 
N17Cdc42 (but not N17Rac) in these cells, however, resulted in 
a decrease in cell spreading and stimulated the extension of 
neurites (Fig. 9, G and H). Thus, NOMA-GAP enables neurite 
Figure 8.  NOMA-GAP regulates the ERK5 MAP kinase pathway. (A and B) Ras/MAP kinase activity is required for NOMA-GAP induced neurite extension. 
PC12 cells were transiently transfected with control or wt NOMA-GAP expression constructs in the presence or absence of an expression construct for 
N17Ras and stimulated 24 h later with NGF in the presence or absence of 20 μM U0126. (A) Samples were ﬁ  xed and stained 72 h later for the GFP 
transfection marker (green) and for polymerized actin (red). Bars, 20 μm. (B) Quantiﬁ  cation of the proportion of GFP-expressing cells bearing long neuronal 
processes (>100 μm). (C) NOMA-GAP activates ERK-dependent Elk1 transcriptional activation of a ﬁ  reﬂ  y luciferase reporter gene in RK13 epithelial cells. 
Samples are normalized on renilla luciferase expression. The average of duplicate experiments is shown. (D–F) NOMA-GAP activates ERK5 MAP kinase 
in PC12 cells. PC12 cells were transiently transfected with the indicated Myc-tagged NOMA-GAP constructs or with control vector and stimulated with NGF 
for 24 h (D) or for the indicated times (E). Lysates were analyzed by Western blot as indicated. (F) Quantiﬁ  cation of the levels of phospho-ERK5 normalized 
on the α-tubulin loading control for the experiment shown in E. (G) NOMA-GAP is required for the sustained activation of ERK5 downstream of NGF. PC12 
cells were transfected with control (C) or rat NOMA-GAP (N) siRNA in the presence or absence of expression constructs for wt and Y1169A huNOMA-GAP 
and stimulated 24 h later with NGF for the indicated times. Lysates were immunoblotted as indicated. Vertical lines denote nonconsecutive lanes from the 
same gel and Western blot.JCB • VOLUME 178 • NUMBER 3 • 2007  512
outgrowth downstream of NGF signaling by tempering Cdc42 
activation. At higher levels of N17Cdc42, neurite outgrowth is 
also inhibited in these cells, indicating that this GTPase has a 
function, albeit at controlled levels, in neurite outgrowth.
Discussion
We have here identifi  ed a novel regulator of neuronal process 
extension, the neurite outgrowth multiadaptor RhoGAP protein, 
Figure 9.  NOMA-GAP negatively regulates Cdc42 and PAK downstream of NGF. (A and B) PC12 cells were transfected with control (C) or rat NOMA-GAP 
(N) siRNA in the absence (A) or presence (B) of expression constructs for wt and Y1169A huNOMA-GAP as described in Fig. 8 G. Lysates were immuno-
blotted as indicated. Vertical lines denote nonconsecutive lanes from the same gel and Western blot. (C) GST-PAK CRIB pull-downs were performed on ly-
sates of PC12 cells transfected 24 h earlier with control or rat NOMA-GAP siRNA and stimulated with NGF. Pull-downs and lysates were immunoblotted 
as indicated. (D and E) PC12 cells were transiently transfected with dominant-active (V12) Cdc42, wt NOMA-GAP, and a GFP transfection marker as indi-
cated and stimulated with NGF 24 h after transfection. (D) Samples were stained 72 h after transfection for polymerized actin (red) and GFP (green). Bar, 
20 μm. (E) Quantiﬁ  cation of the proportion of cells forming large lamellipodia (>30 μm diameter) in duplicate samples. (F–H) PC12 cells were transfected 
with control siRNA or NOMA-GAP siRNA in the presence of increasing levels of an expression construct for Myc-tagged dominant-negative (N17) Cdc42 
and a GFP transfection marker. Cells were stimulated with NGF 4 h after transfection and were then either lysed 48 h after transfection and analyzed for 
expression of Myc-tagged N17 Cdc42 (F) or stained 72 h after transfection for polymerized actin (red) and GFP (green) (H). Bar, 20 μm. Asterisk marks 
a nonspeciﬁ  c band. (G) Quantiﬁ  cation of the proportion of NGF-stimulated control or NOMA-GAP siRNA-transfected cells bearing neurites (>30 μm) in 
the presence of increasing levels of N17Cdc42 or N17Rac. The normalized average of two independent experiments is shown.NEURONAL DIFFERENTIATION BY NOMA-GAP • ROSÁRIO ET AL. 513
NOMA-GAP, which has both multiadaptor and enzymatic 
functions that are essential for the transduction of signals and 
biological activity of NGF/TrkA. In particular, we demon-
strate that NOMA-GAP plays two distinct and crucial roles 
downstream of NGF signaling: promotion of SHP2/ERK5 
signaling and tempering the activation of the Cdc42/PAK 
signaling pathway.
Regulation of SHP2 and ERK5 
by NOMA-GAP
NOMA-GAP synergizes with NGF in promoting the extension 
of neuronal processes in PC12 cells and induces neuronal dif-
ferentiation in the developing chick spinal cord. We show that 
NOMA-GAP is constitutively associated with the NGF receptor, 
TrkA, through a direct phosphotyrosine-independent interaction 
involving sequences in the N terminus of NOMA-GAP. Activa-
tion of TrkA results in tyrosine phosphorylation of NOMA-GAP, 
although it is not clear whether this is direct. NGF-stimulated 
tyrosine phosphorylation of NOMA-GAP, however, enables the 
recruitment of the tyrosine phosphatase SHP2.
The tyrosine phosphatase SHP2 has been shown to con-
trol the sustained activation of the ERK1/2 MAP kinases and 
to be required for the extension of neurites downstream of NGF 
(Wright et al., 1997, for review see Neel et al., 2003). ERK5 is 
another ERK kinase that is activated by neurotrophins and that 
in cardiomyocytes is regulated by SHP2 (Nakaoka et al., 2003; 
for review see Wang and Tournier, 2006). We have analyzed the 
inter  action of NOMA-GAP with SHP2, and demonstrate that it 
involves the N-terminal SHP2 SH2 domains and phosphorylation 
of tyrosine 1169 in the C terminus of NOMA-GAP. This type of 
interaction has been shown to result in an activating conforma-
tional change in SHP2 (Lechleider et al., 1993; Ong et al., 1997; 
Hof et al., 1998; Cunnick et al., 2001), and indeed, interaction 
with NOMA-GAP results in activation of SHP2. Furthermore, 
we demonstrate that association of SHP2 with NOMA-GAP is 
required for the extension of neuronal processes.
NOMA-GAP–stimulated neurite extension is inhibited by 
the ERK MAP kinase pathway inhibitor U0126 and by dominant-
negative Ras. However, both ERK1/2 and ERK5 are sensitive 
to U0126 and can be activated downstream of Ras in PC12 
cells (English et al., 1998; Kamakura et al., 1999). We demon-
strate that NOMA-GAP is specifi  cally required for the sustained 
activation of ERK5, but not of ERK1/2, downstream of NGF. 
Furthermore, SHP2 plays a critical role downstream of NOMA-
GAP in the activation of ERK5.
Several other multiadaptor proteins have been shown to 
interact with TrkA and to activate ERK1/2 MAP kinases (for 
review see Reichardt, 2006). However, their relative impor-
tance is poorly understood. Nevertheless, Shc has been shown 
to mediate transient activation of ERK1/2 kinases, while both 
FRS-2 and the membrane-spanning protein ARMS/Kidins220 
have been proposed to regulate sustained activation of ERK1/2 
(Kao et al., 2001; Arevalo et al., 2004, 2006). The molecular 
mechanisms linking the TrkA to ERK5 activation were un-
known. This study, thus, identifi  es the fi  rst multiadaptor protein, 
NOMA-GAP, that specifi  cally regulates ERK5 downstream 
of NGF.
Negative regulation of Cdc42 
by NOMA-GAP downstream of NGF
Unlike other multiadaptor proteins associated with TrkA, NOMA-
GAP also contains an enzymatic domain, the RhoGAP domain, 
which specifi  cally binds to active forms of the RhoGTPase, 
Cdc42. Previous in vitro GTPase assays using the isolated 
RhoGAP domain of NOMA-GAP, report a similar preference 
for Cdc42 (Chiang et al., 2003). Cdc42 regulates various as-
pects of neuronal differentiation including neurite outgrowth 
and extension (for review see Govek et al., 2005). However, 
paradoxically, both active and inactive mutants of Cdc42 have 
been reported to inhibit neurite outgrowth and neuronal differ-
entiation (Luo et al., 1994; Allen et al., 2000; Aoki et al., 2004). 
NGF-driven differentiation of PC12 cells normally proceeds 
through a two-step process where cells initially spread and 
produce lamellipodia and unstable fi  lopodia and then extend 
stable neurites (Greene and Tischler, 1976; Aoki et al., 2004). 
Expression of a dominant-active mutant of Cdc42 results not in 
neurite outgrowth but in fi  lopodia formation and cell spreading 
(Nobes and Hall, 1995; Daniels et al., 1998; Aoki et al., 2004), 
which can be counteracted by coexpression of NOMA-GAP. 
Indeed, the RhoGAP domain of NOMA-GAP is required for 
the extension of neuronal processes. Furthermore, we show 
that down-regulation of NOMA-GAP in PC12 cells results in 
  elevated levels of active Cdc42 and the Cdc42 effector, PAK, 
which can be rescued by reexpression of NOMA-GAP. Thus, 
NOMA-GAP is an important negative regulator of Cdc42 sig-
naling downstream of NGF. This signaling function is essential 
to permit neurite outgrowth. PC12 cells with down-regulated 
NOMA-GAP undergo cell spreading and fail to extend neurites. 
Moreover, neurite outgrowth can be rescued by coexpression 
of low levels of dominant-negative Cdc42. Higher levels of 
dominant-negative Cdc42 are also inhibitory to neurite outgrowth 
in PC12 cells with down-regulated NOMA-GAP. This suggests 
that although excessive activation of Cdc42, as induced by NGF 
in the absence of NOMA-GAP, is counterproductive to neurite 
outgrowth and extension, low levels or spatially restricted acti-
vation of Cdc42 are still required. Interestingly, GTP-Cdc42 has 
been shown by FRET analysis to be restricted to the micro-
spikes projecting from the neurite tips of NGF-stimulated PC12 
cells and to be absent in the tips themselves (Aoki et al., 2004). 
We show that the opposite is true for NOMA-GAP. Negative 
roles for Cdc42 and Cdc42 effectors have also been described 
by others. For example, the Cdc42 effectors and actin polymer-
ization regulators N-WASP and Toca-1 have been shown to nega-
tively regulate neurite extension in NGF-stimulated PC12 cells 
and in hippocampal neurons (Strasser et al., 2004; Kakimoto 
et al., 2006). Additionally, in Drosophila neurons Cdc42 has 
been shown to inhibit axon growth and guidance through a 
PAK-LIMK-cofi  lin pathway (Ng and Luo, 2004). Work with 
PAK and LIMK null mice also suggests that these Cdc42 effec-
tors are required for the later maturation of dendritic spines but 
not for axon outgrowth (for review see Boda et al., 2006).
Finally, the role of NOMA-GAP in the promotion of 
neuronal process outgrowth may have implications for human 
pathology. We have demonstrated that NOMA-GAP is a nec-
essary player in NGF-stimulated signaling. In humans, TrkA JCB • VOLUME 178 • NUMBER 3 • 2007  514
mutations are associated with congenital insensitivity to pain 
with anhydrosis (Indo et al., 1996), while reduced NGF sig-
naling may be involved in the pathology of Alzheimer’s dis-
ease and Downs syndrome (Capsoni et al., 2000; Salehi et al., 
2006). Moreover, NOMA-GAP regulates at least two signaling 
pathways which are key to the regulation of neurite outgrowth 
and neuronal function: SHP2/ERK5 and Cdc42/PAK. Muta-
tional activation of SHP2 is linked to the multi-symptomatic 
Noonan syndrome and to various human malignancies, in 
particular pediatric leukemias and neuroblastoma (Tartaglia 
et al., 2003; Bentires-Alj et al., 2004).On the other hand, loss-
of-function of several regulators of Cdc42, including huPak3, 
is associated with human mental retardation (for review see 
Govek et al., 2005). Analysis of NOMA-GAP signaling and 
function has provided novel insights into the regulation of 
neurite outgrowth and extension by NGF and may therefore 
lead to a better understanding into the development of human 
neurodegenerative conditions.
Materials and methods
Plasmid construction, RT-PCR, and reagents
Full-length human NOMA-GAP was subcloned from ESTs AW166303, 
AL137579, and BG772651 (RZPD Deutshces Ressourcenzentrum für 
  Genomforschung GmbH, Berlin, Germany) into the mammalian expression 
vector pEFmyc.2. The N and C termini of NOMA-GAP and full-length hu-
man SHP2 were subcloned into the yeast expression vectors pGBT9, 
pGADT7 (CLONTECH Laboratories, Inc.), and pSrcBridge. pSrcBridge 
was generated by subcloning nonmyristoylated (G2E) active (Y416F 
Y527F) chicken Src into the second multiple cloning site of pBridge (CLON-
TECH Laboratories, Inc.). NOMA-GAP deletion and point mutants were 
subcloned into pEFmyc.2. NOMA-GAP C terminus was subcloned into 
pcDNA3Flag (Invitrogen). Wild-type and dominant-negative (delP muta-
tion; provided by Dr. A.M. Bennett, Yale University School of Medicine, 
New Haven, CT; Tang et al., 1995) SHP2 were subcloned into pEF HA.6. 
Point mutations were inserted by PCR using oligonucleotide primers con-
taining respective base substitutions. Y527F Src pEF and all pEF vectors 
have been described previously (Rosário et al., 1999). Control siRNA and 
NOMA-GAP siRNA were purchased from Dharmacon (siCONTROL Non-
Targeting siRNA pool D-001206-13-20 and siGENOME SMARTpool 
D-050940, respectively). A pool of the following NOMA-GAP siRNAs was 
used: G  U  A  C  A  G  A  A  A  U  G  G  A  G  G  A  C  A  U  U  U  , G  G  A  C  A  G  A  C  C  A  G  A  A  G  U  U  A  C-
U  U  U  , and G  A  G  G  U  C  C  U  G  U  U  C  A  G  C  G  A  U  A  U  U  . The siRNAs were also tested 
singly with similar effects. RICS siRNA has been previously described (Zhao 
et al., 2003). The following antibodies were used: Anti-Neuroﬁ  lament 68, 
anti-α-tubulin, and anti-phospho-ERK1/2 (from Sigma-Aldrich); anti-HA tag 
(Roche); anti-NeuN antibody (Chemicon International); anti-Myc (A14), 
anti-SHP2 (C18), and anti-Trk (C14) antibodies from Santa Cruz Bio-
technology, Inc.; Fast-Track anti-NOMA-GAP antibody (AbCam); anti-
GFP antibody (Invitrogen); anti-Shc antibody (Upstate Biotechnology); anti-
phospho-ERK5 (Biosource International); anti-ERK1/2, anti-phospho- tyrosine, 
anti-PAK1/2, and anti-phospho PAK1/2 from Cell Signaling Technology; 
and anti-Grb2, anti-Cdc42, and anti-phospho tyrosine PY20 from BD Trans-
duction Laboratories. Polymerized actin was stained with Phalloidin-Texas 
red (Sigma-Aldrich), the lipophilic styryl dye FM 1-43FX (Invitrogen) was 
used to stain cell membranes and TOTO-3 (Invitrogen) was used to stain 
nuclei for counting NeuN staining in chick embryos. All ﬂ  uorescent second-
ary antibodies (Cy2, Cy3, and Cy5) were from Jackson Laboratories. 
Phospho-speciﬁ  c and total protein immunoblotting for a given protein 
was performed simultaneously on duplicate Western blots. U0126 was 
from Calbiochem.
Cell culture, transfection, and in ovo electroporation
PC12 cells were grown at 37°C and 5% CO in DME (Invitrogen) sup-
plemented with 10% horse serum and 5% fetal calf serum. Stimulations 
were carried after overnight culture in media with reduced serum (2.5% 
horse and 1.25% fetal calf serum) with 100 μg/μl (or 25 μg/μl for low 
levels) of NGF (Promega). DNA transfections were performed according 
to the manufacturer’s instructions using LipofectAMINE 2000 (Invitrogen). 
40 ng of pEGFP-C1 (CLONTECH Laboratories, Inc.) were used as a transfec-
tion marker. For transfections, PC12 cells were seeded onto poly-D-lysine/
laminin-coated coverslips (BD Biosciences) or on poly-DL-ornithine/laminin 
(Sigma-Aldrich) coated tissue culture plates and transfected 24 h later. 
Fertilized chick eggs (Charles River Laboratories) were incubated at 38°C in a 
humidiﬁ  ed incubator and unilateral in ovo electroporations were performed 
at room temperature using a T820 electro-squareporator (BTX, Inc.).
Immunoﬂ  uorescence and in situ hybridization
For immunoﬂ  uorescence, PC12 cells were prepared as described previ-
ously (Rosário et al., 2001). siRNA-transfected PC12 cells were stimulated 
with NGF 4 h after transfection and analyzed 72 h after transfection. 
PC12 cells overexpressing NOMA-GAP constructs were stimulated with 
low levels of NGF 24 h after transfection and analyzed 72 h after transfec-
tion. In PC12 differentiation assays, at least 150 GFP-positive cells were 
scored from random ﬁ  elds per condition and per experiment for the pres-
ence of short (30–100 μm) or long (>100 μm) processes. Mean pixel in-
tensity of immunoﬂ   uorescent staining for endogenous NOMA-GAP was 
determined for GFP-positive cells from jointly stained samples using LSM 5 
Pascal version 3.2 software. Immunoﬂ  uorescent staining of chick embryos 
was performed on 12-μm cryosections. Samples were analyzed at room 
temperature using a confocal microscope (LSM 510 META) equipped with 
Plan-Neoﬂ  uar 40× 0.75 objective (all from Carl Zeiss MicroImaging, Inc.) 
and the software package LSM 5 Pascal version 3.2. In situ hybridizations 
were performed at room temperature using digoxygenin-labeled (Roche) 
RNA probes as previously described (Huelsken et al., 2000). Photos were 
taken at room temperature with an AxioCam HRC camera mounted on an 
Axioskop microscope with 10× and 20× Plan-Neoﬂ   uar objectives (all 
from Carl Zeiss MicroImaging, Inc.). Images were adjusted for contrast 
and image size using Adobe Photoshop 7.0.
Statistical analysis of results
Results were analyzed using the statistical package SPSS. The multiple test 
of ANOVA was used to test the null hypotheses of equality of means of dif-
ferent groups in experiments with multiple conditions. The error probabil-
ities of particular pairwise tests were corrected by Bonferroni. A t test 
was used to compare the means of experiments with only two conditions. 
Probabilities are summarized as asterisks above the graphs as follows: 
*, P < 0.05; **, P < 0.01.
Cell lysis, immunoprecipitations, and Rho family GTPase pull-downs
For endogenous coimmunoprecipitations and for whole-cell lysates, PC12 
cells were lysed on ice in IP buffer (50 mM Tris, 100 mM NaCl, 1 mM 
EDTA, and 1% vol/vol Triton X-100, pH 7.4) containing protease and 
phosphatase inhibitors (10 μg/ml Leupeptin, 10 μg/ml Aprotinin, 5 μg/ml 
Pepstatin A, 1 mM Benzamidine, 0.5 μg/ml Microcystin LR, and 1 mM 
Na3VO4; all from Sigma-Aldrich). For immunoprecipitations of Myc-tagged 
NOMA-GAP, lysates were prepared on ice in RIPA buffer (50 mM Tris, 150 
mM NaCl, 1% vol/vol NP-40, 0.1% wt/vol SDS, and 0.5% wt/vol deoxy-
cholate, pH 8.0) containing protease and phosphatase inhibitors. Immuno-
precipitations were performed at 4°C for 1–2 h using equal amounts of 
protein (determined by Bradford assay) and using antibodies precoupled 
to protein G–Sepharose 4 Fast Flow (GE Healthcare) or, for Myc immuno-
precipitations with anti-Myc agarose beads (Sigma-Aldrich), and subse-
quently washed thoroughly with lysis buffer. Cdc42 pull-downs were 
performed as described previously (Ogita and Takai, 2006) using recom-
binant GST-PAK CRIB (see Fig. S4). PC12 lysates for pull-downs were pre-
pared on ice in pull-down buffer (50 mM Tris, 100 mM NaCl, 1% vol/vol 
Triton X-100, 0.1% wt/vol SDS, 0.5% wt/vol deoxycholate, and 1 mM 
DTT, pH 7.4) containing protease and phosphatase inhibitors, incubated 
for 30 min at 4°C with GST-PAK CRIB precoupled to Glutathione-Sepharose 
4B beads (GE Healthcare), and then washed thoroughly in IP buffer con-
taining 1 mM DTT and protease inhibitors. Images were processed and 
quantiﬁ  ed using Adobe Photoshop 7.0.
SHP2 phosphatase and Elk1 transactivation assays
For SHP2 phosphatase assays, NIH3T3 cells were lysed on ice 24 h after 
transfection in Hepes buffer (25 mM Hepes, 100 mM NaCl, 1% vol/vol 
Triton X-100, 40% Glycerol, and 1 mM EDTA, pH 7.0) containing protease 
inhibitors, clariﬁ   ed by centrifugation, and incubated with recombinant 
GST-tagged wild-type SHP2 at 4°C (see Fig. S4). GST-SHP2 was recovered 
by incubation with Glutathione-Sepharose beads. SHP2 activity was as-
sayed at room temperature on para-Nitrophenylphosphate (pNPP) as de-
scribed previously (Niu et al., 1999). Elk1 transactivation assays were 
performed using the PathDetect Elk1 trans-Reporting System (Stratagene). 
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using the Dual-Luciferase Reporter Assay System kit (Promega) 24 h after 
transfection of RK13 epithelial cells.
Yeast two-hybrid analysis
Plasmids were cotransfected into yeast (S. cerevisiae Y190, AH109, and 
L40 strains; CLONTECH Laboratories, Inc.) as previously described 
(Rosário et al., 1999).), and plated on selection (−His-Leu-Trp+/− Met) 
or on total growth plates (−Leu-Trp) and grown at 32°C in a humidiﬁ  ed 
  incubator. A human brain cDNA library (HY4004AH; CLONTECH Labora-
tories, Inc.) was used for screening.
Online supplemental material
Fig. S1 shows NOMA-GAP family of multiadaptors. Fig. S2 shows ex-
pression of NOMA-GAP in the murine brain and eye. Fig. S3 shows 
  expression of huNOMA-GAP deletion and mutant proteins in PC12 cells. 
Fig. S4 shows recombinant GST-SHP2 and GST-PAK CRIB proteins. Fig. S5 
shows binding of RhoGTPase proteins to the NOMA-GAP RhoGAP domain. 
Online supplemental material is available at http://www.jcb.org/cgi/
content/full/jcb.200609146/DC1.
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